HeraMED Ltd. (AU:HMD) has released an update.
HeraMED Ltd. has announced a promising Letter of Intent with Founda Health to potentially partner and integrate its HeraCARE maternity care solution within Founda’s healthcare data exchange platform. This strategic move aims to enhance digital maternity care by leveraging Founda’s extensive customer network and interoperability technology. The collaboration is set to identify the first hospital for integration, marking a significant step in HeraMED’s global expansion and digital transformation of maternity care.
For further insights into AU:HMD stock, check out TipRanks’ Stock Analysis page.
